MiNK Therapeutics (INKT) Stock Chart & Stock Price History → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free INKT Stock Alerts $1.01 -0.03 (-2.88%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media MiNK Therapeutics Stock Price Performance5 Day Performance-2.88%1 Month Performance+15.26%3 Month Performance+7.57%6 Month Performance-5.61%Year-To-Date Performance-5.61%1 Year Performance-43.26% Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry INKT Stock Chart for Monday, May, 20, 2024 INKT Chart by TradingView MiNK Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$1.04$1.01-2.88%$1.04$0.9868,762 shs$35.08 million05/16/2024$1.04$1.04$1.10$0.9876,498 shs$36.09 million05/15/2024$1.12$1.04-7.14%$1.30$0.93560,202 shs$36.09 million05/14/2024$0.98$1.12+14.31%$1.16$0.98625,100 shs$38.86 million05/13/2024$0.90$0.98+8.87%$1.08$0.954.58 million shs$34.00 million05/10/2024$0.91$0.90-1.25%$0.92$0.8920,100 shs$31.23 millionShocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company05/09/2024$0.93$0.91-2.00%$0.93$0.86135,734 shs$31.63 million05/08/2024$0.93$0.93-0.01%$0.95$0.9218,971 shs$32.27 million05/07/2024$0.94$0.93-1.13%$0.97$0.9258,814 shs$32.27 million05/06/2024$0.98$0.94-4.01%$1.01$0.94118,587 shs$32.64 million05/03/2024$0.97$0.98+1.09%$0.99$0.9428,781 shs$34.01 million05/02/2024$0.95$0.97+1.77%$0.97$0.9240,059 shs$33.64 million05/01/2024$0.99$0.95-3.79%$0.99$0.9379,937 shs$33.05 million04/30/2024$0.95$0.99+4.20%$0.99$0.9333,909 shs$34.35 million04/29/2024$0.93$0.95+2.44%$0.98$0.9158,163 shs$32.97 million04/26/2024$0.87$0.93+6.46%$0.93$0.8832,348 shs$32.18 million04/25/2024$0.89$0.87-2.00%$0.92$0.8638,201 shs$30.23 million04/24/2024$0.87$0.89+2.07%$0.93$0.8637,583 shs$30.85 million04/23/2024$0.89$0.87-2.57%$0.93$0.8792,040 shs$30.22 million04/22/2024$0.88$0.89+2.02%$0.91$0.8639,998 shs$31.02 million04/19/2024$0.87$0.88+0.53%$0.90$0.8640,310 shs$30.41 million04/18/2024$0.92$0.87-4.76%$0.96$0.8742,419 shs$30.25 million04/17/2024$0.92$0.92-0.51%$0.93$0.8924,277 shs$31.76 million04/16/2024$0.91$0.92+1.27%$0.94$0.8941,947 shs$31.92 million04/15/2024$0.98$0.91-7.74%$1.02$0.8976,569 shs$31.53 million04/12/2024$1.02$0.98-3.46%$1.03$0.9762,500 shs$34.17 million04/11/2024$1.00$1.02+2.00%$1.05$0.9823,757 shs$35.39 million04/10/2024$1.01$1.00-0.99%$1.11$0.9867,752 shs$34.70 million04/09/2024$1.32$1.01-23.48%$1.37$0.98410,810 shs$35.05 million04/08/2024$1.56$1.32-15.38%$1.58$1.21458,124 shs$45.80 million04/05/2024$1.34$1.56+16.42%$1.90$1.341.52 million shs$54.13 million04/04/2024$0.96$1.34+38.89%$1.35$0.94765,001 shs$46.50 million04/03/2024$0.94$0.96+2.64%$0.98$0.9358,319 shs$33.48 million04/02/2024$0.95$0.94-0.88%$0.96$0.9135,535 shs$32.62 million04/01/2024$0.91$0.95+4.40%$0.95$0.9136,107 shs$32.91 million03/29/2024$0.91$0.91$0.93$0.9035,116 shs$31.52 million03/28/2024$0.91$0.91-0.19%$0.93$0.9035,063 shs$31.52 million03/27/2024$0.94$0.91-2.99%$0.93$0.9134,109 shs$31.58 million03/26/2024$0.92$0.94+1.96%$0.94$0.9035,831 shs$32.55 million03/25/2024$0.87$0.92+5.75%$0.92$0.8744,343 shs$31.92 millionShocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company03/22/2024$0.89$0.87-2.25%$0.89$0.8732,131 shs$30.03 million03/21/2024$0.90$0.89-0.67%$0.91$0.8646,506 shs$30.72 million03/20/2024$0.86$0.90+4.19%$0.91$0.7866,272 shs$30.93 million03/19/2024$0.86$0.86$0.91$0.8518,941 shs$29.69 million03/18/2024$0.89$0.86-3.86%$0.91$0.8638,118 shs$29.69 million03/15/2024$0.89$0.89+0.51%$0.91$0.8138,273 shs$30.88 million03/14/2024$0.91$0.89-2.20%$0.92$0.82143,886 shs$30.72 million03/13/2024$0.91$0.91-0.22%$0.95$0.9051,739 shs$31.41 million03/12/2024$0.95$0.91-3.96%$0.97$0.9125,945 shs$31.48 million03/11/2024$0.96$0.95-1.29%$0.99$0.9050,188 shs$32.78 million03/08/2024$0.93$0.96+3.33%$0.97$0.9222,834 shs$33.21 million03/07/2024$0.98$0.93-4.61%$0.98$0.9343,887 shs$32.14 million03/06/2024$0.98$0.98-0.41%$0.99$0.9288,863 shs$33.69 million03/05/2024$0.98$0.98+0.22%$1.01$0.9363,502 shs$33.83 million03/04/2024$0.95$0.98+2.93%$1.02$0.9497,289 shs$33.75 million03/01/2024$0.92$0.95+3.12%$0.98$0.9229,112 shs$32.79 million02/29/2024$0.95$0.92-3.26%$1.00$0.9152,947 shs$31.80 million02/28/2024$0.94$0.95+1.39%$0.98$0.9262,278 shs$32.87 million02/27/2024$0.92$0.94+1.94%$0.95$0.9334,058 shs$32.42 million02/26/2024$0.90$0.92+2.37%$0.93$0.909,451 shs$31.80 million02/23/2024$0.93$0.90-2.93%$0.94$0.8935,711 shs$31.07 million02/22/2024$0.92$0.93+0.78%$0.94$0.8840,412 shs$32.01 million02/21/2024$0.94$0.92-2.01%$0.95$0.9131,061 shs$31.76 million02/20/2024$0.92$0.94+2.17%$0.95$0.9119,327 shs$32.41 million02/19/2024$0.92$0.92$0.97$0.8850,300 shs$31.72 million Related Companies: Quince Therapeutics Stock Chart Estrella Immunopharma Stock Chart SAB Biotherapeutics Stock Chart Cyclo Therapeutics Stock Chart Achilles Therapeutics Stock Chart Pluri Stock Chart OKYO Pharma Stock Chart Brainstorm Cell Therapeutics Stock Chart Dyadic International Stock Chart Surrozen Stock Chart This page (NASDAQ:INKT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding MiNK Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.